CY1114678T1 - METHODS FOR DETERMINING THE ACTIVITY OF ADILUMUMUM IN SUBJECTS HAVE AN ANGYLUMIC SPHYLITE WITH USE II - Google Patents

METHODS FOR DETERMINING THE ACTIVITY OF ADILUMUMUM IN SUBJECTS HAVE AN ANGYLUMIC SPHYLITE WITH USE II

Info

Publication number
CY1114678T1
CY1114678T1 CY20131101001T CY131101001T CY1114678T1 CY 1114678 T1 CY1114678 T1 CY 1114678T1 CY 20131101001 T CY20131101001 T CY 20131101001T CY 131101001 T CY131101001 T CY 131101001T CY 1114678 T1 CY1114678 T1 CY 1114678T1
Authority
CY
Cyprus
Prior art keywords
activity
determining
sphylite
angylumic
adilumumum
Prior art date
Application number
CY20131101001T
Other languages
Greek (el)
Inventor
Walter P Maksymowych
Robert L Wong
Original Assignee
Abbvie Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06849865.8A external-priority patent/EP1948235B1/en
Application filed by Abbvie Biotechnology Ltd filed Critical Abbvie Biotechnology Ltd
Publication of CY1114678T1 publication Critical patent/CY1114678T1/en

Links

Abstract

Η εφεύρεση παρέχει μια μέθοδο για τον καθορισμό της δραστικότητας ενός αναστολέα του TNFα, όπως ένα αντίσωμα του TNFα, ή ένα μέρος πρόσδεση αντιγόνου αυτού, για τη θεραπεία αγκυλοποιητικής σπονδυλίτιδας (ΑΣ), με τη χρησιμοποίηση ενός βιοδείκτη αποδόμησης κολλαγόνου ή/και ενός βιοδείκτη αρθροθυλακίτιδας.The invention provides a method for determining the activity of a TNFα inhibitor, such as a TNFα antibody, or an antigen binding part thereof, for the treatment of ankylosing spondylitis (PM), using a collagen degradation marker and / or arthritis biomarker. .

CY20131101001T 2005-11-01 2013-11-12 METHODS FOR DETERMINING THE ACTIVITY OF ADILUMUMUM IN SUBJECTS HAVE AN ANGYLUMIC SPHYLITE WITH USE II CY1114678T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73244405A 2005-11-01 2005-11-01
EP06849865.8A EP1948235B1 (en) 2005-11-01 2006-10-31 Methods for determining efficacy of adalimumab in subjects having ankylosing spondylitis using ctx-ii and mmp3 as biomarkers

Publications (1)

Publication Number Publication Date
CY1114678T1 true CY1114678T1 (en) 2016-10-05

Family

ID=58448821

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131101001T CY1114678T1 (en) 2005-11-01 2013-11-12 METHODS FOR DETERMINING THE ACTIVITY OF ADILUMUMUM IN SUBJECTS HAVE AN ANGYLUMIC SPHYLITE WITH USE II

Country Status (1)

Country Link
CY (1) CY1114678T1 (en)

Similar Documents

Publication Publication Date Title
CY1123503T1 (en) APTAMERI THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT RELATED DISORDERS
CY1123400T1 (en) HUMAN ANTI-IL-23 ANTIBODIES, COMPOSITIONS, METHODS AND USES
CY1120070T1 (en) METHOD OF THERAPEUTIC TREATMENT WITH THE USE OF ANTI-ERBB-METHYSINEOID ANTIBODY conjugates
CY1111629T1 (en) HUMAN PARTICULARS SPECIAL FOR KDR AND THEIR USES
CY1113400T1 (en) CHANGE OF CONNECTION CONNECTIONS WITH FCRN OR TRANSFERRED HALF-TERM HALF
CY1115731T1 (en) SUSPENSION FACTOR TOY MIC-1
CY1110923T1 (en) CONCLUSION CONTAINING AN ANTIBODY SPECIFIC TO THE ED-B AREA OF INONEKTIN AND USE FOR INSPECTION AND ANTITION
ATE550354T1 (en) HUMAN RING-SPECIFIC BNP ANTIBODIES
TW200736611A (en) Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
ATE456666T1 (en) METHOD FOR EVALUATION OF RIBONUCLEOTIDE SEQUENCES
CY1113037T1 (en) HUMAN ANTIBODY ANTI-RECEPTORS OF EPIDEMIOLOGICAL GROWTH FACTOR
CY1118200T1 (en) Polypeptides, polynucleotides and compositions for use in the treatment of latent tuberculosis
BRPI0411437B8 (en) stent for use in the non-vascular or vascular field, method for its manufacture and kit comprising this stent
CY1118244T1 (en) ANTIBODIES AGAINST IL-25
CY1107453T1 (en) BAFF, RELATED BINDING FACTORS AND THEIR USE IN THE STIMULATION AND INHIBITION OF B CELLS AND IMMUNOSPHEREINS IN IMMUNE RESPONSES
CY1112739T1 (en) ANTI-CD79B ANTIBODIES AND IMMUNIZATIONS AND METHODS OF USE
DE602004019812D1 (en) MARKERS FOR NEUROMYELITIS OPTICA
TNSN08255A1 (en) Anti-mn antibodies and methods of using same
NO20054351L (en) Monoclonal antibody and hybridoma producing this
DK1761879T3 (en) Methods, systems and software for identifying functional biomolecules
CY1119737T1 (en) NEW COMPOSITIONS AND METHODS
ATE425266T1 (en) APTAMER NANOPARTICLE CONJUGATES AND METHODS OF USE FOR DETECTING TARGET ANALYTES
BRPI1013688A8 (en) IL-17 BINDING PROTEINS.
EA201390146A1 (en) ANTIBODIES TO MATRIX METALLOPROTEINASE 9
RS53215B (en) Neutralising antibodies having specificity for human il-17